The U.S. Federal Trade Commission (FTC) and Applied Food Sciences (AFS) have reached an agreement settling FTC charges that AFS “used the results of a flawed study to make baseless weight-loss claims about its green coffee extract to retailers, who repeated those claims in marketing finished products to consumers,” according to a September 8, 2014, FTC press release. FTC v. Applied Food Scis., No. 14-851 (U.S. Dist. Ct., W.D. Tex., order entered September 8, 2014). The FTC complaint accused AFS of citing a study as scientific proof for green coffee extract’s weight-loss benefits despite its significant flaws, including the alteration of key subject measurements, adjustment of the trial’s length and confusion over which subjects took AFS’s Green Coffee Antioxidant (GCA) product and which took a placebo during different trial phases. Under the settlement agreement, AFS will pay $3.5 million, and, in addition, it cannot claim that GCA causes weight or fat loss—or any other health benefits—without competent and reliable scientific evidence.